Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR), a U.S.-based producer of uranium, rare earth elements (REEs), and critical minerals, reported its first quarter 2026 financial results, revealing $956.6 million in working capital, $36 million in revenue, and $8.3 million in cash from operating activities. The company also posted a reduced net loss of $10.8 million for the quarter, while producing 790,000 pounds of finished U3O8, the processed form of uranium.
The results highlight Energy Fuels’ continued progress across its diversified portfolio, which includes uranium, rare earth elements, heavy mineral sands, vanadium, and medical isotope development. The company’s strong working capital position provides financial flexibility to advance its projects, which are strategically important for U.S. supply chains in nuclear energy and clean technology.
Energy Fuels has been the top U.S. producer of natural uranium concentrate, supplying nuclear utilities. The company owns the only fully licensed conventional uranium mill operating in the United States—the White Mesa Mill in Utah—where it also produces REE products and evaluates medical isotope recovery for emerging cancer therapies. This mill is critical for processing uranium and rare earth materials, positioning Energy Fuels as a key player in domestic critical mineral production.
In addition to its uranium operations, Energy Fuels is developing three heavy mineral sands and rare earth projects internationally: the Vara Mada Project in Madagascar, the Bahia Project in Brazil, and the Donald Project in Australia, which is held through a joint venture with Astron Limited. These projects are aimed at securing diverse supplies of rare earth elements and heavy mineral sands, which are essential for electronics, defense, and clean energy technologies.
The company’s progress in rare earth production is particularly significant given the growing global demand for these materials, which are used in electric vehicles, wind turbines, and military applications. By advancing its REE capabilities, Energy Fuels is helping to reduce reliance on foreign sources, especially from China, which dominates the rare earth market.
Energy Fuels is also exploring the recovery of medical isotopes from its mill, targeting emerging cancer therapies. This diversification into medical applications could open new revenue streams and contribute to healthcare innovations.
The company’s financial strength and operational achievements in Q1 2026, including reduced net losses and positive cash flow from operations, demonstrate its ability to manage costs while investing in growth. For investors and industry observers, Energy Fuels’ quarterly report provides a snapshot of a company well-positioned to benefit from the increasing demand for uranium for nuclear power and rare earths for advanced technologies.
To view the full press release, visit https://ibn.fm/r07Hd. For the latest news and updates on Energy Fuels, go to http://ibn.fm/UUUU.
